Nurses should monitor cutaneous toxicity in chemotherapy regimens with paclitaxel.
Knobf
M T
MT
Ambulatory Service, Yale School of Nursing, USA.
Staugaard
C
C
D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D017239:Paclitaxel / Q000009:adverse effects*; D012871:Skin Diseases / Q000139:chemically induced*
D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel